Global Blood Glucose Monitoring Systems Market, by Product Type (Self-Monitoring Blood Glucose Systems, Continuous Glucose Monitoring Systems ), By Testing Site (Fingertip Testing, Alternate Site Testing), By Application (Type-1 Diabetes, Type-2 Diabetes, Gestational Diabetes), By End-Use (Self/Home Care, Hospital & Clinics),and by Region and Companies Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032.

Blood Glucose Monitoring System Market Overview:

The global blood glucose monitoring systems market is projected to reach a valuation of USD 23,443.83 Mn by 2031 at a CAGR of 6.7%, from USD 12,257.01 Mn in 2021.

Market.US announces the publication of a research report titled, “Global Blood Glucose Monitoring Systems Market, by Product Type (Self-Monitoring Blood Glucose Systems (Blood Glucose Meters, Testing Strips, Lancets & Lancing Devices), Continuous Glucose Monitoring Systems (Sensors, Transmitters, Receivers), By Testing Site (Fingertip Testing, Alternate Site Testing), By Application (Type-1 Diabetes, Type-2 Diabetes, Gestational Diabetes), By End-Use (Self/Home Care, Hospital & Clinics), and by Region – Global Forecast to 2031.” This report offers a holistic view of the global blood glucose monitoring systems market through systematic segmentation that covers every aspect of this target market.

Glucometers, or portable blood glucose meters, are used to keep track of blood sugar levels. These tests examine a small amount of blood, usually taken from the tip of a finger. A lancet softly pricks the skin to obtain this blood. Blood sugar meters indicate how high or low your blood sugar is at any one time. Checking your blood sugar levels regularly is the most critical thing you can do to treat Type-1 or Type-2 diabetes. Individuals will be able to examine how a change in food, medicine, or activity affects the indicated outcome.

Blood glucose monitoring systems are classified as the process of assessing levels in the blood, an important aspect of routine diabetic therapy. It helps identify blood glucose levels that are below a target range. Blood glucose monitoring devices aid in the tracking of patient progress, as well as in observing the effects of medications and treatment on blood glucose levels, providing useful information for diabetes management.

Blood glucose meters help people with diabetes, including Type-1, Type-2, and gestational diabetes. Diabetes is rapidly becoming more a commonly observed condition around the world, with Type-2 diabetes mellitus affecting 90% of these individuals. Self-Monitoring Blood Glucose (SMBG) and Continuous Glucose Monitoring (CGM) are the two basic forms of blood glucose monitoring systems.

Blood glucose monitoring reveals individual patterns of blood glucose swings, which aids in meal preparation, task completion, and medication administration. Furthermore, monitoring allows for a quick response to high (hyperglycemia) or low (hypoglycemia) blood sugar levels (hypoglycemia).

Insulin and glucagon are hormones that control the quantity of glucose in the blood. These hormones are produced by the pancreas and act on liver cells. The liver acts as a ‘reservoir’ for glucose in the body.

Global Blood Glucose Monitoring Systems Market Revenue (US$ Mn), 2021–2031

The increasing number of diabetes patients is a primary factor fueling the global glucose monitoring system market. The adoption of an unhealthy lifestyle, a poor diet, excessive alcohol consumption, and a lack of physical activity all contribute to an increase in the number of individuals with diabetes. Furthermore, as the expense of healthcare surges, so does the cost of self-monitoring blood glucose levels.

The key elements of the demand for glucose monitoring devices are anticipated to be booming geriatric populations and the high prevalence of individuals with diabetes. The surging use of continuous monitoring systems, as well as technological advancements in blood glucose monitoring devices, are augmenting the market for glucose monitoring devices.

Furthermore, as individuals become more aware of diabetes prevention techniques and the launch of new forms of medication, global demand is expected to continue to increase. Consumer demand is expected to be fueled by the adoption of cutting-edge healthcare technology and increasing disposable incomes in urban regions.

A key issue leading to the decreased adoption of blood glucose monitoring systems, especially in emerging nations, is the presence of a substantial number of individuals living as undiagnosed diabetics. When compared to developed countries, the incidence of delayed diagnosis is higher in developing countries such as China, India, South Africa, Brazil, etc. This can be accredited to the lack of knowledge concerning chronic diseases such as diabetes mellitus.

Additionally, the lack of standardized norms by government or private groups, as well as limited access to sophisticated healthcare infrastructure, are elements that could potentially stymie this market’s further expansion.

Key market players have enabled real-time monitoring for insulin-dependent patients by introducing new technologies such as Continuous Blood Glucose Monitoring (CGM) systems. When compared to Self-Monitoring Blood Glucose (SMBG) devices, CGM systems have various advantages, including being less intrusive, comfortable, real-time monitoring, as well as quick and precise readings. These particular advantages afforded by CGM devices are key drivers for healthcare practitioners and patients to utilize CGM systems.

Furthermore, merely a few companies are now focused on non-invasive CGM system R&D, with only a few devices being launched in the European market. As a result, increased CGM penetration and market players shifting their perspectives towards non-invasive blood monitoring systems are two important industry trends.

This research report on the global blood glucose monitoring systems market includes major company profiles such as

• F. Hoffmann-La Roche Ltd.
• Abbott
• LifeScan IP Holdings LLC
• Ascensia Diabetes Care Holdings AG
• Medtronic, Dexcom Inc.
• Ypsomed AG
• B. Braun Melsungen AG
• Nipro Europe Group Companies
• Prodigy Diabetes Care LLC.
• and ARKRAY USA Inc.
• among others.

The Global Blood Glucose Monitoring Systems Market Segmentation is Based on Product Type, Testing Site, Application, End-Use, and Region

Based on Product Type

• Self-Monitoring Blood Glucose Systems
  • Blood Glucose Meters
  • Testing Strips
  • Lancets & Lancing Devices
• Continuous Glucose Monitoring Systems
  • Sensors
  • Transmitters
  • Receivers

Based on the Testing Site

• Fingertip Testing
• Alternate Site Testing

Based on Application

• Type-1 Diabetes
• Type-2 Diabetes
• Gestational Diabetes

Based on End-Use

• Self/Home Care
• Hospital & Clinics

Based on Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa